Skip to main content

Table 2 Univariable analysis of clinical and CMR characteristics for prediction of adverse events

From: Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease

  MACE Cardiovascular mortality
  Hazard ratio (95% CI) p value Hazard ratio (95% CI) p value
Age 1.02 (1.01–1.03) 0.002 1.03 (1.02–1.05) < 0.001
Male 1.68 (1.27–2.21)  < 0.001 1.60 (1.16–2.20) 0.004
Body mass index 0.98 (0.95–1.02) 0.311 1.01 (0.95–1.03) 0.485
Hypertension 0.83 (0.62–1.10) 0.190 0.88 (0.63–1.22) 0.431
Diabetes mellitus 0.86 (0.64–1.15) 0.307 0.87 (0.62–1.23) 0.429
Dyslipidemia 1.00 (0.76–1.32) 0.978 1.00 (0.73–1.38) 0.978
Current or previous smoking 0.96 (0.68–1.35) 0.811 0.81 (0.53–1.22) 0.309
Family history of coronary artery disease 0.72 (0.51–1.02) 0.064 0.61 (0.40–0.94) 0.023
Stroke 0.77 (0.37–1.83) 0.371 0.74 (0.30–1.19) 0.466
Renal failure 1.36 (0.44–4.26) 0.595 1.27 (0.31–5.12) 0.738
Peripheral atheroma 1.12 (0.29–3.37) 0.566 1.54 (0.34–4.45) 0.319
Prior hospitalization for heart failure 1.57 (0.74–3.34) 0.240 1.87 (0.83–4.24) 0.133
Presence of ischemia 4.64 (3.49–6.17)  < 0.001 4.00 (2.85–5.61) < 0.001
Number of segments of ischemia 1.60 (1.51–1.70)  < 0.001 1.51 (1.40–1.62) < 0.001
Presence of unrecognized MI 2.88 (2.08–3.99)  < 0.001 2.77 (1.89–4.06) < 0.001
Number of segments of LGE 1.52 (1.41–1.63)  < 0.001 1.49 (1.37–1.62) < 0.001
LV ejection fraction, per 10% 0.88 (0.79–0.97) 0.014 0.93 (0.82–1.05) 0.245
LV end-diastolic volume index, per 10 ml/m2 1.06 (1.01–1.11) 0.025 1.03 (0.97–1.09) 0.348
LV end-systolic volume index, per 10 ml/m2 1.06 (1.02–1.13) 0.009 1.04 (0.97–1.11) 0.252
RV ejection fraction, % 0.96 (0.79–1.19) 0.411 1.06 (0.78–1.53) 0.681
  1. CI confidence interval, CMR cardiovascular magnetic resonance, LGE late gadolinium enhancement, LV left ventricle, MACE major adverse cardiac events, MI myocardial infarction, RV right ventricle